Search For "serum"
DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
Read More
Serum Institute says will adhere to DCGI instructions after show cause ove
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a show-cause notice Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about
Read More
DCGI sends show cause notice to Serum Institute for not pausing trial of
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
Read More
Oxford COVID-19 vaccine trials not paused in India, clarifies Serum Instit
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Read More
Oxford COVID-19 vaccine's phase two trial begins at Pune hospital
Updated : 5 years, 6 months ago IST
Pune (Maharashtra) [India], Aug 26 (ANI): The second phase trial of COVID-19 vaccine developed by Oxford University, which would be manufactured by Serum Institute of India, began here with the vaccine candidate administered to two volunteers at Bharati Vidyapeeth Medical College.
Read More
Current claims over Covishield false, vaccine to be commercialised only af
Updated : 5 years, 6 months ago IST
Pune (Maharashtra) [India], Aug 23 (ANI): The current claims over the Coronavirus vaccine, Covishield, are completely false and it will be commercialised when trials prove successful and regulatory approvals are in place, said Serum Institute of India (SII) on Sunday.
Read More
Serum Institute initiates phase 2, 3 clinical study on 1,600 volunteers fo
Updated : 5 years, 6 months ago IST
New Delhi [India], August 19 (ANI): Indian pharmaceutical giant Serum Institute of India has initiated the phase 2, 3 clinical trials to evaluate the safety and immune response of coronavirus vaccine candidate on healthy Indian adults after the pharma company got approval from Drugs Controll
Read More
'Secret behind high speed of Russia's COVID-19 vaccine creation was the co
Updated : 5 years, 7 months ago IST
Moscow [Russia], August 11 (ANI): After the first coronavirus vaccine in the world was registered in Russia, Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev said, in his opinion piece for Sputnik, that the secret behind the high speed of Russia's COVID-19 vaccine creation was the c
Read More
SII enters into new partnership to accelerate manufacture, delivery of COV
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 7 (ANI): The Serum Institute of India (SII) has entered into a new landmark partnership with Gavi, the Vaccine Alliance and the Bill and Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for India and l
Read More
Here's how blueberry-enriched diet may help women's muscle growth, repair
Updated : 5 years, 7 months ago IST
California [US], Aug 5 (ANI): A new research study investigated how serum from subjects consuming a diet enriched with blueberries would affect the cells responsible for muscle growth and repair.
Read More
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine tria
Updated : 5 years, 7 months ago IST
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on
Read More
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in
Updated : 5 years, 7 months ago IST
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Read More